Connect with us

Technology

Tecsys Reports Financial Results for the First Quarter of Fiscal 2025

Published

on

SaaS subscription bookings up 57%, SaaS RPO climbs 40%

MONTREAL, Sept. 5, 2024 /CNW/ — Tecsys Inc. (TSX: TCS), an industry-leading supply chain management SaaS company, today announced its results for the first quarter of fiscal 2025, ended July 31, 2024. All dollar amounts are expressed in Canadian currency and are prepared in accordance with International Financial Reporting Standards (IFRS).

“We kicked off fiscal 2025 with solid momentum, setting a positive tone for the year ahead,” said Peter Brereton, president and CEO at Tecsys. “Our continued SaaS performance is supported by the strength of our team and the impact of our partners, together driving growth in a highly engaged market. The supply chain market is on the move, and we like our competitive position. We are confident in our ability to build on this strong start.”

Mark Bentler, chief financial officer of Tecsys Inc., added, “Our Q1 fiscal 2025 financial performance showcases 57% SaaS bookings growth, 40% SaaS RPO growth and 33% SaaS revenue growth compared to the same quarter last year and we are pleased that our underlying SaaS margins continue to trend positively.” 

First Quarter Highlights:

SaaS revenue increased by 33% to $15.3 million, up from $11.5 million in Q1 2024.SaaS subscription bookingsi (measured on an ARRi basis) increased by 57% to $3.0 million, compared to $1.9 million in the first quarter of fiscal 2024.SaaS Remaining Performance Obligation (RPOi) increased by 40% to $194.9 million at July 31, 2024, up from $139.4 million at the same time last year.Total revenue increased to $42.3 million compared to $42.0 million in Q1 2024.Net profit was $0.8 million or $0.05 per share on a fully diluted basis in Q1 2025, compared to $1.2 million or $0.08 per share for the same period in fiscal 2024.Adjusted EBITDAii was $2.6 million compared to $3.2 million reported in Q1 last year.In the first quarter of fiscal 2025, Tecsys acquired 59,600 of its outstanding common shares for approximately $2.2 million as part of its ongoing Normal Course Issuer Bid.

Financial Guidance:

Tecsys is reiterating previously presented financial guidance as follows:

FY25 Guidance

FY26 Guidance

Total Revenue Growth

7-9%

n.a.

SaaS Revenue Growth

30-32%

n.a.

Adjusted EBITDAii Margin

8-9%

10-11%

On September 5, 2024, the Company declared a quarterly dividend of $0.08 per share to be paid on October 4, 2024 to shareholders of record on September 20, 2024.

Pursuant to the Canadian Income Tax Act, dividends paid by the Company to Canadian residents are considered to be “eligible” dividends.

Q1 2025 Financial Results Conference Call
Date: September 6, 2024
Time: 8:30 a.m. ET
Phone number: 800-836-8184 or 646-357-8785
The call can be replayed until September 13, 2024, by calling:
888-660-6345 or 646-517-4150 (access code: 81086#)

i See Key Performance Indicators in Management’s Discussion and Analysis of the Q1 2025 Financial Statements.

ii See Non-IFRS Performance Measures in Management’s Discussion and Analysis of the Q1 2025 Financial Statements.

About Tecsys

Tecsys is a global provider of advanced supply chain solutions. With a commitment to innovation and customer success, the company equips organizations with the essential software, technology and expertise needed for operational excellence and competitive advantage. Its cloud solutions serve a diverse range of industries, including healthcare, distribution and converging commerce, across multiple complex, regulated and high-volume markets. Built on the Itopia® low-code application platform, Tecsys’ offerings include enterprise resource planning, warehouse management, consolidated service management, distribution and transportation management, supply management at the point of use and order management solutions. Tecsys provides critical data insights and control across the supply chain, ensuring that organizations are agile, responsive and scalable.

Tecsys is publicly traded on the Toronto Stock Exchange under the ticker symbol TCS. For more about Tecsys and its solutions, please visit www.tecsys.com.

Forward Looking Statements
The statements in this news release relating to matters that are not historical fact are forward-looking statements that are based on management’s beliefs and assumptions. Such statements are not guarantees of future performance and are subject to a number of uncertainties, including but not limited to future economic conditions, the markets that Tecsys Inc. serves, the actions of competitors, major new technological trends, and other factors beyond the control of Tecsys Inc., which could cause actual results to differ materially from such statements. More information about the risks and uncertainties associated with Tecsys Inc.’s business can be found in the MD&A section of the Company’s annual report and the most recently filed annual information form. These documents have been filed with the Canadian securities commissions and are available on our website (www.tecsys.com) and on SEDAR+ (www.sedarplus.ca).

Copyright © Tecsys Inc. 2024. All names, trademarks, products, and services mentioned are registered or unregistered trademarks of their respective owners.

Non-IFRS Measures

Reconciliation of EBITDA and Adjusted EBITDA

EBITDA is calculated as earnings before interest expense, interest income, income taxes, depreciation and amortization. Adjusted EBITDA is calculated as EBITDA before stock-based compensation and restructuring costs. The exclusion of interest expense, interest income, income taxes and restructuring costs eliminates the impact on earnings derived from non-operational activities and non-recurring items, and the exclusion of depreciation, amortization and stock-based compensation eliminates the non-cash impact of these items.

The Company believes that these measures are useful measures of financial performance without the variation caused by the impacts of the items described above and that could potentially distort the analysis of trends in our operating performance. In addition, they are commonly used by investors and analysts to measure a company’s performance, its ability to service debt and to meet other payment obligations, or as a common valuation measurement. Excluding these items does not imply that they are necessarily non-recurring. Management believes these non-IFRS financial measures, in addition to conventional measures prepared in accordance with IFRS, enable investors to evaluate the Company’s operating results, underlying performance and future prospects in a manner similar to management. Although EBITDA and Adjusted EBITDA are frequently used by securities analysts, lenders and others in their evaluation of companies, they have limitations as an analytical tool, and should not be considered in isolation, or as a substitute for analysis of the Company’s results as reported under IFRS.

The reconciliation of EBITDA and Adjusted EBITDA to the most directly comparable IFRS measure is provided below.

       Three months

         Trailing 12 months

       ended July 31,

            ended July 31,

(in thousands of CAD)

2024

2023

2024

2023

Net profit for the period

$

798

$

1,171

$

1,476

$

3,220

Adjustments for:

Depreciation of property and equipment and right-of-use assets

371

384

1,464

1,729

Amortization of deferred development costs

197

142

638

536

Amortization of other intangible assets

334

396

1,431

1,603

Interest expense

25

38

150

325

Interest income

(217)

(269)

(963)

(851)

Income taxes

436

859

218

2,458

EBITDA

$

1,944

$

2,721

$

4,414

$

9,020

Adjustments for:

Stock based compensation

647

452

2,496

2,153

Restructuring costs

2,122

Adjusted EBITDAii

$

2,591

$

3,173

$

9,032

$

11,173

 

Condensed Interim Consolidated Statements of Financial Position
(Unaudited)

(In thousands of Canadian dollars)

July 31, 2024

April 30, 2024

Assets

Current assets

Cash and cash equivalents

$

10,705

$

18,856

Short-term investments

16,358

16,713

Accounts receivable

19,691

22,090

Work in progress

6,739

4,248

Other receivables

449

134

Tax credits

7,708

6,422

Inventory

2,073

1,359

Prepaid expenses and other

8,294

9,143

Total current assets

72,017

78,965

Non-current assets

Other long-term receivables and assets

552

421

Tax credits

4,914

4,737

Property and equipment

1,319

1,372

Right-of-use assets

1,147

1,251

Contract acquisition costs

4,466

4,478

Deferred development costs

2,938

2,683

Other intangible assets

7,450

7,703

Goodwill

17,470

17,363

Deferred tax assets

9,073

9,073

Total non-current assets

49,329

49,081

Total assets

$

121,346

$

128,046

Liabilities

Current liabilities

Accounts payable and accrued liabilities

18,153

20,030

Deferred revenue

33,261

36,211

Lease obligations

826

812

Total current liabilities

52,240

57,053

Non-current liabilities

Other long-term accrued liabilities

339

496

Deferred tax liabilities

840

826

Lease obligations

1,094

1,302

Total non-current liabilities

2,273

2,624

Total liabilities

$

54,513

$

59,677

Equity

Share capital

$

52,394

$

52,256

Contributed surplus

7,992

9,417

Retained earnings

7,735

8,121

Accumulated other comprehensive loss

(1,288)

(1,425)

Total equity attributable to the owners of the Company

66,833

68,369

Total liabilities and equity

$

121,346

$

128,046

 

Condensed Interim Consolidated Statements of Income and Comprehensive Income
(Unaudited)

(In thousands of Canadian dollars, except per share data)

Three Months Ended July 31,

2024

2023

Revenue:

SaaS

$

15,314

$

11,495

Maintenance and Support

8,715

8,298

Professional Services

13,387

14,908

License

861

456

Hardware

3,999

6,818

Total revenue

42,276

41,975

Cost of revenue

22,548

22,475

Gross profit

19,728

19,500

Operating expenses:

Sales and marketing

8,352

7,671

General and administration

2,978

2,959

Research and development, net of tax credits

7,331

7,112

Total operating expenses

18,661

17,742

Profit from operations

1,067

1,758

Other income

167

272

Profit before income taxes

1,234

2,030

Income tax expense

436

859

Net profit

$

798

$

1,171

Other comprehensive income (loss):

Effective portion of changes in fair value on designated revenue hedges

(20)

2,573

Exchange differences on translation of foreign operations

157

(426)

Comprehensive income

$

935

$

3,318

Basic and diluted earnings per common share

$

0.05

$

0.08

 

Condensed Interim Consolidated Statements of Cash Flows
(Unaudited)

(In thousands of Canadian dollars)

Three Months Ended July 31,

2024

2023

Cash flows from operating activities:

Net profit

$

798

$

1,171

Adjustments for:

Depreciation of property and equipment and right-of-use-assets

371

384

Amortization of deferred development costs

197

142

Amortization of other intangible assets

334

396

Interest (income) expense and foreign exchange (gain) loss

(167)

(272)

Unrealized foreign exchange and other

(123)

(1,198)

Non-refundable tax credits

(429)

(440)

Stock-based compensation

647

452

Income taxes

3

14

Net cash from operating activities excluding changes in non-cash working capital items related to operations

1,631

649

Accounts receivable

2,434

(1,820)

Work in progress

(2,486)

(829)

Other receivables and assets

(520)

(262)

Tax credits

(1,034)

(1,071)

Inventory

(714)

(842)

Prepaid expenses

903

(283)

Contract acquisition costs

(39)

3

Accounts payable and accrued liabilities

(3,119)

(3,566)

Deferred revenue

(2,961)

1,376

Changes in non-cash working capital items related to operations

(7,536)

(7,294)

Net cash used in operating activities

(5,905)

(6,645)

Cash flows from financing activities:

Payment of lease obligations

(198)

(199)

Interest paid

(25)

(38)

Issuance of common shares on exercise of stock options

277

1,763

Shares repurchased and cancelled

(2,211)

Net cash (used in) provided by financing activities

(2,157)

1,526

Cash flows from investing activities:

Interest received

24

36

Transfers from short-term investments

548

22

Acquisitions of property and equipment

(209)

(102)

Deferred development costs

(452)

(247)

Net cash used in investing activities

(89)

(291)

Net decrease in cash and cash equivalents during the period

(8,151)

(5,410)

Cash and cash equivalents – beginning of period

18,856

21,235

Cash and cash equivalents – end of period

$

10,705

$

15,825

 

Condensed Interim Consolidated Statements of Changes in Equity
(Unaudited)

(In thousands of Canadian dollars, except number of shares)

Share capital

Contributed
Surplus

 

Accumulated other
comprehensive
(loss) income

Retained
earnings

Total

Number

Amount

Balance, May 1, 2024

14,840,150

$

52,256

$

9,417

$

(1,425)

$

8,121

$

68,369

Net profit

798

798

Other comprehensive (loss) income:

Effective portion of changes in fair value on designated revenue hedges

(20)

(20)

Exchange difference on translation of foreign operations

157

157

Total comprehensive income

137

798

935

Shares repurchased and cancelled

(59,600)

(210)

(2,001)

(2,211)

Stock-based Compensation

647

647

Dividends to equity owners

(1,184)

(1,184)

Share options exercised

12,537

348

(71)

277

Total transactions with owners of the Company

(47,063)

$

138

(1,425)

$

$

(1,184)

$

(2,471)

Balance, July 31, 2024

14,793,087

$

52,394

7,992

$

(1,288)

$

7,735

$

66,833

Balance, May 1, 2023

14,582,837

$

44,338

15,285

$

(17)

$

10,832

$

70,438

Net profit

1,171

1,171

Other comprehensive income:

Effective portion of changes in fair value on designated revenue hedges

2,573

2,573

Exchange difference on translation of foreign operations

(426)

(426)

Total comprehensive income

2,147

1,171

3,318

Stock-based Compensation

452

452

Dividends to equity owners

(1,102)

(1,102)

Share options exercised

111,306

2,307

(544)

1,763

Total transactions with owners of the Company

111,306

$

2,307

(92)

$

$

(1,102)

$

1,113

Balance, July 31, 2023

14,694,143

$

46,645

15,193

$

2,130

$

10,901

$

74,869

 

SOURCE Tecsys Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

The Hottest Dog Bronchial Health Supplement on Shopee in 2024

Published

on

By

SEOUL, South Korea, Nov. 10, 2024 /PRNewswire/ — As a dog owner, you may have often heard your furry friend coughing, whether it’s a dry hack or a honking sound. Though it might seem trivial, these coughs can cause serious discomfort for your furry friend and create anxiety for you as a caring pet parent.

DOCTORBY’s BREATH CARE is a nutritional supplement designed to support bronchial health in dogs, currently gaining attention among many pet owners on Shopee.

Coughing in dogs can be triggered by various factors, including temperature fluctuations, strong air conditioning, and dust or debris inhaled during walks. Additionally, as dogs age, their bronchial immunity can weaken, leading to potential health issues.

BREATH CARE contains a blend of functional ingredients like the plant-based complex extract TF-343, magnesium, and propolis, which can help alleviate respiratory issues such as coughing and support the elimination of waste accumulated in the bronchial passages.[1] With a taste dogs love, it doubles as a treat, making it incredibly easy for pet owners to administer. Furthermore, it has passed heavy metal and toxicity tests, ensuring safety without the use of synthetic sweeteners or colorings.

Currently, BREATH CARE ranks as one of the top products in Shopee’s pet nutrition and supplement category. In May 2024, it achieved the number one sales position in the pet nutrition category on Shopee Singapore, garnering immense popularity. Shopee has reported a staggering 3,000% growth in sales compared to 2023. Notably, DOCTORBY has not only topped the charts on Shopee but has also held the number one position on Amazon Japan for 22 consecutive weeks, establishing itself as a leader in the South Korean pet nutrition market and rapidly expanding in the global market.

For cat owners, the cat-specific bronchial supplement, CAT BREATH CARE, is also enjoying tremendous popularity. Additionally, DOCTORBY offers a variety of health supplements, including ‘SKIN & COAT’ for skin support, ‘EYES CARE’ for eye health and tear stain improvement, and ‘HAIRBALL CARE’ to assist with hairball elimination in cats. In Singapore, DOCTORBY products are exclusively available on Shopee.

Enjoy fast delivery via Shopee’s reliable fulfillment services, with most orders arriving within 2 to 3 days for a satisfying shopping experience. Shopee also hosts monthly promotional events, such as Double Day and Pay Day, offering a range of exciting deals. Moreover, a special Mega Day event is planned for November 11, promising additional benefits for shoppers.

[1] Korean J. Food Sci. Technol. Vol.35, no.5, pp980-987 (2003)

 

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/the-hottest-dog-bronchial-health-supplement-on-shopee-in-2024-302299805.html

SOURCE DOCTORBY

Continue Reading

Technology

LG Display Succeeds in Developing World’s First Stretchable Display that Expands by 50 Percent

Published

on

By

SEOUL, South Korea , Nov. 9, 2024 /PRNewswire/ — LG Display, the world’s leading innovator of display technologies, announced today its unveiling of the world’s first Stretchable display capable of expanding up to 50%, the highest rate of elongation in the industry. At LG Science Park in Seoul on Nov. 8, the company demonstrated the panel at a meeting of more than 100 South Korean industry, academia, and research stakeholders involved in a Stretchable display national project.

Stretchable displays are seen as the ultimate free-form screen technology because they can be freely transformed into any shape, including by stretching, folding, and twisting.

The new prototype features a 12-inch screen that stretches up to 18 inches, while simultaneously delivering a high resolution of 100ppi (pixels per inch) and full red, green, and blue (RGB) color.

Compared to the first Stretchable display prototype unveiled in 2022, the new panel’s maximum elongation rate has more than doubled from 20% to 50%. This enhanced stretchability enables various display design possibilities, raising the technology’s potential competitiveness when commercialized.

By applying a number of new technologies, such as improving the properties of a special silicon material substrate used in contact lenses and developing a new wiring design structure, LG Display improved the panel’s stretchability and flexibility, exceeding the original national project’s target of 20% elongation.

In addition, by using a micro-LED light source of up to 40μm (micrometers), the new prototype’s strengthened durability means it can be repeatedly stretched over 10,000 times, maintaining clear image quality even in extreme environments such as exposure to low or high temperatures and external shocks.

Stretchable displays are not only thin and lightweight but also capable of adhering to irregularly curved surfaces like clothing and skin. They are expected to be widely applied in various industries, from fashion and wearables to mobility.

The company showcased numerous concepts for the application of Stretchable displays, including an automotive panel that stretches out into a convex shape and can be operated by hand as well as a wearable display attached to firefighters’ uniforms that provides real-time information.

LG Display was selected as the lead company for the national project to develop Stretchable displays in 2020 and since then has been conducting joint R&D with 19 domestic industry and research institutes. It is one of the major tasks of a wider project to develop core technologies for next-generation displays promoted by South Korea’s Ministry of Trade, Industry and Energy (MOTIE) along with the Korea Planning & Evaluation Institute of Industrial Technology.

By successfully completing the project, LG Display has not only secured core technologies that can lead the next-generation display market but also contributed to localizing materials, components, and equipment as well as building an R&D infrastructure.

“We will continue to build a sustainable future display ecosystem through close cooperation between South Korean industry, academia, and research stakeholders,” said Soo-young Yoon, CTO and Executive Vice President of LG Display.

About LG Display

LG Display Co., Ltd. [NYSE: LPL, KRX: 034220] is the world’s leading innovator of display technologies, including thin-film transistor liquid crystal and OLED displays. The company manufactures display panels in a broad range of sizes and specifications primarily for use in TVs, notebook computers, desktop monitors, automobiles, and various other applications, including tablets and mobile devices. LG Display currently operates manufacturing facilities in Korea and China, and back-end assembly facilities in Korea, China, and Vietnam. The company has approximately 70,707 employees operating worldwide. For more news and information about LG Display, please visit www.lgdisplay.com.

Media Contact:
Joo Yeon Jennifer Ha, Manager, Communication Team
Email: hjy05@lgdisplay.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/lg-display-succeeds-in-developing-worlds-first-stretchable-display-that-expands-by-50-percent-302300599.html

SOURCE LG Display

Continue Reading

Technology

Stay Better in China: Tell the Beautiful China to the World

Published

on

By

NANCHANG, China, Nov. 9, 2024 /PRNewswire/ — A report from Jiangxi International Communication Center (JXICC): Komurcu Busra, an international student from Nanchang University, talks about her life in China. She felt the simplicity of Chinese countryside and pure beauty of nature here. She wants to tell the beautiful China to the world.

https://www.youtube.com/watch?v=vQGbRJc4ncc

View original content to download multimedia:https://www.prnewswire.com/news-releases/stay-better-in-china-tell-the-beautiful-china-to-the-world-302277393.html

SOURCE Jiangxi International Communication Center(JXICC)

Continue Reading

Trending